Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives

W Xu, K Liu, M Chen, JY Sun… - … in medical oncology, 2019 - journals.sagepub.com
The introduction of immunotherapies has been a major development in the treatment of
many advanced cancers, including hepatocellular carcinoma (HCC). We are entering a new …

immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects

A Lombardi, MU Mondelli - Alimentary Pharmacology & …, 2019 - Wiley Online Library
Background Immune checkpoint inhibitors have revolutionised the oncological landscape in
the last few years. Possible applications include the treatment of hepatocellular carcinoma …

programmed cell death protein‐1‐targeted immunotherapy for advanced hepatocellular carcinoma.

X Liu, RR Jia, CY Zhang - Alimentary Pharmacology & …, 2019 - search.ebscohost.com
Letter: programmed cell death protein‐1‐targeted immunotherapy for advanced hepatocellular
carcinoma Page 1 340 | LETTERS TO THE EDITORS © 2019 John Wiley & Sons Ltd DOI …

programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre …

TH Kung, CC Wang - Alimentary Pharmacology & …, 2019 - search.ebscohost.com
Letter: programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced
hepatocellular carcinoma: efficacy and s Page 1 230 | wileyonlinelibrary.com/journal/apt Aliment …

[图书][B] Epigenomic profiling of primary hepatocellular carcinoma reveals super-enhancer-associated chromatin regulator network

L Xu - 2019 - search.proquest.com
Epigenomic Profiling of Primary Hepatocellular Carcinoma Reveals Super-enhancer-associated
Chromatin Regulator Network XU, Liang Page 1 Epigenomic Profiling of Primary …

programmed cell death protein‐1‐targeted immunotherapy for advanced hepatocellular carcinoma–authors' reply.

B Scheiner, M Pinter - Alimentary Pharmacology & …, 2019 - search.ebscohost.com
Letter: programmed cell death protein‐1‐targeted immunotherapy for advanced hepatocellular
carcinoma–authors' reply Page 1 | 341 LETTERS TO THE EDITORS © 2019 John Wiley & Sons …